Stockholm - Delayed Quote SEK

Vaxxa AB (VAXXA.ST)

Compare
1.0400
0.0000
(0.00%)
At close: 3:23:11 PM GMT+1
Loading Chart for VAXXA.ST
DELL
  • Previous Close 1.0400
  • Open 0.9650
  • Bid 1.0000 x --
  • Ask 1.0300 x --
  • Day's Range 0.9650 - 1.1600
  • 52 Week Range 0.6800 - 2.0000
  • Volume 104,595
  • Avg. Volume 104,431
  • Market Cap (intraday) 38.715M
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Vaxxa AB operates an auction platform, vaxxa.se, which offers private individuals and companies to sell and buy used objects in vehicles, machinery, and construction industry. The company was formerly known as Augeo Group AB and changed its name to Vaxxa AB in July 2023. Vaxxa AB was incorporated in 2015 and is based in Stockholm, Sweden.

vaxxa.se

7

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VAXXA.ST

View More

Performance Overview: VAXXA.ST

Trailing total returns as of 1/28/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

VAXXA.ST
8.77%
OMX Stockholm 30 Index
6.14%

1-Year Return

VAXXA.ST
4.00%
OMX Stockholm 30 Index
11.20%

3-Year Return

VAXXA.ST
87.12%
OMX Stockholm 30 Index
16.10%

5-Year Return

VAXXA.ST
92.85%
OMX Stockholm 30 Index
48.78%

Compare To: VAXXA.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VAXXA.ST

View More

Valuation Measures

Annual
As of 1/27/2025
  • Market Cap

    38.71M

  • Enterprise Value

    33.63M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.38

  • Price/Book (mrq)

    2.22

  • Enterprise Value/Revenue

    0.37

  • Enterprise Value/EBITDA

    11.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.31%

  • Return on Assets (ttm)

    1.17%

  • Return on Equity (ttm)

    2.04%

  • Revenue (ttm)

    92.4M

  • Net Income Avi to Common (ttm)

    286k

  • Diluted EPS (ttm)

    -0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.62M

  • Total Debt/Equity (mrq)

    3.09%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: VAXXA.ST

View More

Company Insights: VAXXA.ST

Research Reports: VAXXA.ST

View More